ASKA Pharmaceutical Co., Ltd. Stock Japan Exchange
Stocks
4514
JP3541200006
Pharmaceuticals
OTC Markets Traded| Market Cap | 63.72B 392M 343M 316M 292M 550M 37.79B 562M 3.78B 1.49B 18.51B 1.47B 1.44B | P/E 2027 * |
13.6x | P/E 2028 * | 11.5x |
|---|---|---|---|---|---|
| Enterprise Value | 63.72B 392M 343M 316M 292M 550M 37.79B 562M 3.78B 1.49B 18.51B 1.47B 1.44B | EV / Sales 2027 * |
0.87x | EV / Sales 2028 * | 0.85x |
| Free-Float |
61.83% | Yield 2027 * |
2.9% | Yield 2028 * | 3.12% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tomohito Nagao
CEO | Chief Executive Officer | - | - |
Sota Yamaguchi
PSD | President | 42 | 24/06/2025 |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 24/06/2025 | |
Atsushi Maruo
BRD | Director/Board Member | 67 | 01/04/2021 |
Sota Yamaguchi
BRD | Director/Board Member | 42 | 01/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -4.29% | - | - | 392M | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.11% | +0.54% | +28.13% | +55.82% | 397.23B | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 73.12B 450M 394M 363M 335M 631M 43.37B 645M 4.34B 1.71B 21.24B 1.69B 1.65B | 74.96B 462M 403M 372M 343M 647M 44.46B 661M 4.45B 1.75B 21.77B 1.73B 1.7B |
| Net income | 4.67B 28.76M 25.13M 23.19M 21.38M 40.29M 2.77B 41.18M 277M 109M 1.36B 108M 106M | 5.52B 34.02M 29.73M 27.44M 25.29M 47.67M 3.28B 48.72M 328M 129M 1.6B 128M 125M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
